Nurix Therapeutics, Inc.
NRIX
$9.55
$0.020.21%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.62% | 125.29% | 111.73% | 73.09% | 57.60% |
| Total Receivables | 3,350.00% | 162.50% | 87.50% | -71.43% | -40.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 36.60% | 93.05% | 22.21% | 14.20% | -17.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.46% | 124.61% | 109.60% | 70.20% | 55.24% |
|
|
|||||
| Total Current Assets | 14.46% | 124.61% | 109.60% | 70.20% | 55.24% |
| Net Property, Plant & Equipment | 45.57% | -5.00% | -4.28% | 72.41% | 66.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 79.07% | 53.90% | -14.06% | -17.30% | -14.20% |
| Total Assets | 15.76% | 96.70% | 88.23% | 66.65% | 45.75% |
|
|
|||||
| Total Accounts Payable | 111.66% | 41.89% | 79.38% | 79.15% | -37.83% |
| Total Accrued Expenses | 62.67% | 48.55% | 42.55% | 24.82% | 28.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -34.02% | -9.18% | 7.01% | 22.21% | 42.11% |
| Total Finance Division Other Current Liabilities | -39.42% | -26.73% | -14.33% | 50.63% | 6.97% |
| Total Other Current Liabilities | -39.42% | -26.73% | -14.33% | 50.63% | 6.97% |
| Total Current Liabilities | -6.39% | 2.70% | 10.23% | 40.33% | 11.79% |
|
|
|||||
| Total Current Liabilities | -6.39% | 2.70% | 10.23% | 40.33% | 11.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 123.59% | -8.52% | -12.26% | 679.33% | 455.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -44.04% | -29.90% | -41.79% | 191.50% | 163.39% |
| Total Liabilities | 2.58% | -6.81% | -8.22% | 83.85% | 54.72% |
|
|
|||||
| Common Stock & APIC | 28.35% | 68.80% | 69.57% | 43.13% | 37.63% |
| Retained Earnings | -32.84% | -35.52% | -35.50% | -35.17% | -35.39% |
| Treasury Stock & Other | 85.19% | 164.57% | 122.90% | 128.01% | 92.91% |
| Total Common Equity | 20.75% | 184.99% | 162.85% | 61.18% | 42.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.75% | 184.99% | 162.85% | 61.18% | 42.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.75% | 184.99% | 162.85% | 61.18% | 42.62% |
|
|
|||||